Lv5
1410 积分 2023-08-02 加入
Asundexian versus Apixaban in Patients with Atrial Fibrillation
26天前
已完结
A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms
1个月前
已完结
Structure-based design and synthesis of novel FXIa inhibitors targeting the S2' subsite for enhanced antithrombotic efficacy
1个月前
已完结
The impact of OCEANIC-AF and the future of factor XIa inhibitors
1个月前
已完结
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
1个月前
已完结
Biomedical applications of tannic acid
1个月前
已完结
Biology of factor XI
3个月前
已完结
Biology of factor XI
3个月前
已关闭
Hepato-Cardio-Renal Syndrome
3个月前
已完结
Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial
4个月前
已完结
皖公网安备34019202002308
